Paul Bolno - Nov 25, 2024 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Signature
/s/ Paul B. Bolno
Stock symbol
WVE
Transactions as of
Nov 25, 2024
Transactions value $
-$626,000
Form type
4
Date filed
11/27/2024, 09:00 PM
Previous filing
Nov 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WVE Ordinary Shares Options Exercise $124K +50K +23% $2.48 267K Nov 25, 2024 Direct F1
transaction WVE Ordinary Shares Sale -$750K -50K -18.7% $15.00 217K Nov 25, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WVE Share Option (right to buy) Options Exercise $0 -50K -51.14% $0.00 47.8K Nov 25, 2024 Ordinary Shares 50K $2.48 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024.
F2 These share options are fully vested.